Overview

Combined Vasopressin, Methylprednisolone, and Epinephrine for Inhospital Cardiac Arrest

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
A randomized controlled trial did not show benefit of vasopressin versus epinephrine in inhospital cardiac arrest. Preceding laboratory data suggest that combined vasopressin and epinephrine ensure long-term survival and neurologic recovery. Also, postresuscitation abnormalities mimic severe sepsis. The investigators hypothesized that combined vasopressin and epinephrine during cardiopulmonary resuscitation (CPR), and steroid supplementation during and after (when required) CPR may improve survival in cardiac arrest.
Phase:
Phase 2
Details
Lead Sponsor:
University of Athens
Treatments:
Arginine Vasopressin
Epinephrine
Epinephryl borate
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Racepinephrine
Vasopressins